AstraZeneca

AstraZeneca/Moderna Ink Deal

AstraZeneca/Moderna Ink Deal

Yahoo/Zacks

How AstraZeneca Will Use A Diagnostic To Market Its Blood Thinner

How AstraZeneca Will Use A Diagnostic To Market Its Blood Thinner

Forbes

Can Pascal Soriot Turn Around AstraZeneca? It May Come Down To One Drug

Can Pascal Soriot Turn Around AstraZeneca? It May Come Down To One Drug

Forbes

No Quick Fixes, But Astra's Soriot Can Still Be Bold

No Quick Fixes, But Astra's Soriot Can Still Be Bold

Seeking Alpha

AstraZeneca restructuring will eliminate 1,600 jobs in US, UK and relocate global HQ by 2016

AstraZeneca restructuring will eliminate 1,600 jobs in US, UK and relocate global HQ by 2016

Yahoo/AP

AstraZeneca sees R&D restructuring to result in $1.4B in charges

AstraZeneca sees R&D restructuring to result in $1.4B in charges

Yahoo/Fly on the Wall

Why AstraZeneca Will Disappoint In 2013

Why AstraZeneca Will Disappoint In 2013

Seeking Alpha

Longer Lasting Drugs Make For Longer Lasting Profits

Longer Lasting Drugs Make For Longer Lasting Profits

Seeking Alpha

Puma Biotechnology Priced Like Takeover Target: Real M&A

Puma Biotechnology Priced Like Takeover Target: Real M&A

Bloomberg